Cresset Asset Management LLC Has $2.30 Million Stock Position in CME Group Inc. (NASDAQ:CME)

Cresset Asset Management LLC trimmed its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 65.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,741 shares of the financial services provider's stock after selling 18,414 shares during the quarter. Cresset Asset Management LLC's holdings in CME Group were worth $2,303,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Norges Bank bought a new stake in shares of CME Group during the fourth quarter worth $1,107,389,000. Price T Rowe Associates Inc. MD boosted its stake in CME Group by 89.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock valued at $1,923,047,000 after acquiring an additional 3,921,278 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of CME Group during the 4th quarter valued at $871,063,000. Capital Wealth Planning LLC grew its stake in shares of CME Group by 69.2% during the fourth quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider's stock worth $565,671,000 after purchasing an additional 996,498 shares during the period. Finally, Egerton Capital UK LLP bought a new position in CME Group during the fourth quarter worth about $223,967,000. Institutional investors and hedge funds own 87.75% of the company's stock.

Analysts Set New Price Targets

CME has been the subject of several recent analyst reports. Bank of America upped their target price on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research note on Wednesday, April 2nd. Piper Sandler raised their price target on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 8th. Raymond James upgraded CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective for the company in a research report on Monday, March 10th. Morgan Stanley raised their target price on shares of CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a report on Thursday, April 24th. Finally, Erste Group Bank upgraded shares of CME Group to a "strong-buy" rating in a report on Monday, March 17th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, CME Group currently has a consensus rating of "Hold" and an average target price of $256.80.

CME Group Stock Down 0.8%

NASDAQ CME traded down $2.13 during trading hours on Tuesday, hitting $268.34. 3,001,668 shares of the company traded hands, compared to its average volume of 2,172,771. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The business's 50-day moving average is $264.79 and its 200-day moving average is $246.09. The stock has a market capitalization of $96.70 billion, a price-to-earnings ratio of 27.75, a P/E/G ratio of 6.76 and a beta of 0.45. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $286.48.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. CME Group's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business earned $2.50 EPS. Sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.86%. CME Group's dividend payout ratio (DPR) is 50.30%.

Insider Activity

In other CME Group news, COO Suzanne Sprague sold 1,500 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares in the company, valued at $2,063,885.88. This trade represents a 15.73% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Dennis Suskind sold 1,000 shares of the business's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total transaction of $271,280.00. Following the completion of the sale, the director now directly owns 2,915 shares of the company's stock, valued at approximately $790,781.20. The trade was a 25.54% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 34,726 shares of company stock valued at $8,975,813 over the last ninety days. 0.30% of the stock is currently owned by company insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.